FMC
FMC CORP
Company overview
- Market capitalization
- $1.15B
- Employees
- 5,500
- Latest publication
- 2026-09-29
About FMC CORP
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products. It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q2 20242024-06-30 · USD | Q3 20232023-09-30 · USD | Q1 20232023-03-31 · USD | Q2 20212021-06-30 · USD | Q1 20212021-03-31 · USD | Q3 20202020-09-30 · USD | Q2 20202020-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 867,100,000USD | 1,038,400,000USD | 981,900,000USD | 1,344,300,000USD | 1,242,000,000USD | 1,195,600,000USD | 1,084,600,000USD | 1,155,300,000USD |
| Cost Of Revenue | 525,000,000USD | 647,300,000USD | 553,000,000USD | 759,100,000USD | 691,300,000USD | 661,600,000USD | 605,400,000USD | 617,300,000USD |
| Gross Profit | 342,100,000USD | 391,100,000USD | 428,900,000USD | 585,200,000USD | 550,700,000USD | 534,000,000USD | 479,200,000USD | 538,000,000USD |
| Selling General Administrative | 179,100,000USD | 169,000,000USD | 175,500,000USD | 190,500,000USD | 161,000,000USD | 174,500,000USD | 187,700,000USD | 171,000,000USD |
| Total Operating Expenses | 461,800,000USD | 240,800,000USD | 253,900,000USD | 264,600,000USD | 227,100,000USD | 248,200,000USD | 239,700,000USD | 215,300,000USD |
| Operating Income | -119,700,000USD | 150,300,000USD | 175,000,000USD | 320,600,000USD | 323,600,000USD | 285,800,000USD | 239,500,000USD | 322,700,000USD |
| Total Other Income Expense Net | -74,600,000USD | -155,800,000USD | -143,000,000USD | -72,100,000USD | -72,400,000USD | -62,300,000USD | -90,600,000USD | -97,700,000USD |
| Interest Expense | 71,300,000USD | 63,600,000USD | 64,600,000USD | 51,400,000USD | 32,600,000USD | 32,400,000USD | 35,500,000USD | 40,700,000USD |
| Income Before Tax | -194,300,000USD | -5,500,000USD | 32,000,000USD | 248,500,000USD | 251,200,000USD | 223,500,000USD | 148,900,000USD | 225,000,000USD |
| Income Tax Expense | -1,500,000USD | -303,500,000USD | 27,400,000USD | 41,100,000USD | 33,400,000USD | 32,200,000USD | 18,400,000USD | 29,200,000USD |
| Discontinued Operations | 6,500,000USD | — | -8,300,000USD | -11,500,000USD | -14,600,000USD | -8,100,000USD | -18,400,000USD | -10,800,000USD |
| Net Income | -186,300,000USD | 295,100,000USD | -3,500,000USD | 196,000,000USD | 202,900,000USD | 182,600,000USD | 111,400,000USD | 184,400,000USD |
| Minority Interest | 300,000USD | -100,000USD | 200,000USD | -100,000USD | 23,400,000USD | -600,000USD | 700,000USD | -600,000USD |
| Research Development | — | 75,900,000USD | 80,900,000USD | 78,400,000USD | 65,900,000USD | 74,000,000USD | 71,700,000USD | 64,300,000USD |
| Unclassified Operating Expenses | — | -4,100,000USD | — | -4,300,000USD | — | — | -19,700,000USD | -20,000,000USD |
| Net Interest Income | — | -63,600,000USD | -64,600,000USD | -51,400,000USD | -32,600,000USD | -32,400,000USD | -35,500,000USD | -40,700,000USD |
| Tax Provision | — | -303,500,000USD | 27,400,000USD | 41,100,000USD | 33,400,000USD | 32,200,000USD | 18,400,000USD | 29,200,000USD |
| Net Income From Continuing Ops | — | 298,000,000USD | 4,600,000USD | 207,400,000USD | 217,800,000USD | 191,300,000USD | 130,500,000USD | 195,800,000USD |
| Ebit | — | 57,600,000USD | 96,200,000USD | 298,800,000USD | 281,900,000USD | 255,700,000USD | 185,500,000USD | 265,700,000USD |
| Ebitda | — | 107,600,000USD | 146,300,000USD | 345,800,000USD | 328,100,000USD | 294,200,000USD | 231,000,000USD | 309,100,000USD |
| Depreciation And Amortization | — | 50,000,000USD | 50,100,000USD | 47,000,000USD | 46,200,000USD | 38,500,000USD | 45,500,000USD | 43,400,000USD |
| Reconciled Depreciation | — | 44,300,000USD | 45,600,000USD | 44,700,000USD | 42,500,000USD | 42,600,000USD | 41,500,000USD | 40,100,000USD |
| Interest Income | — | — | 64,600,000USD | 51,400,000USD | 32,600,000USD | 32,400,000USD | 35,500,000USD | 40,700,000USD |
| Net Income Applicable To Common Shares | — | — | -3,500,000USD | 196,000,000USD | 202,900,000USD | 182,600,000USD | 111,400,000USD | 184,400,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD | FY 19951995-12-31 · USD | FY 19941994-12-31 · USD | FY 19911991-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,802,300,000USD | 5,045,200,000USD | 4,642,100,000USD | 4,609,800,000USD | 2,878,600,000USD | 4,509,800,000USD | 4,010,800,000USD | 3,899,400,000USD |
| Cost Of Revenue | 3,415,500,000USD | 2,858,600,000USD | 2,576,700,000USD | 2,618,200,000USD | 1,752,300,000USD | 3,083,200,000USD | 2,712,600,000USD | 2,718,800,000USD |
| Gross Profit | 2,386,800,000USD | 2,186,600,000USD | 2,065,400,000USD | 1,991,600,000USD | 1,126,300,000USD | 1,426,600,000USD | 1,298,200,000USD | 1,180,600,000USD |
| Research Development | 314,200,000USD | 304,700,000USD | 287,900,000USD | 298,100,000USD | 141,500,000USD | — | 166,800,000USD | — |
| Selling General Administrative | 783,800,000USD | 719,700,000USD | 750,900,000USD | 792,900,000USD | 618,600,000USD | 817,800,000USD | 587,700,000USD | — |
| Selling And Marketing Expenses | 8,600,000USD | 5,600,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 1,095,900,000USD | 1,020,100,000USD | 945,000,000USD | 1,015,100,000USD | 621,700,000USD | 1,066,700,000USD | 983,500,000USD | 855,900,000USD |
| Operating Income | 1,290,900,000USD | 1,166,500,000USD | 1,120,400,000USD | 976,500,000USD | 504,600,000USD | 246,900,000USD | 252,300,000USD | 255,900,000USD |
| Interest Income | 151,800,000USD | 131,100,000USD | 100,000USD | 1,900,000USD | 900,000USD | — | — | — |
| Interest Expense | 151,800,000USD | 131,100,000USD | 151,300,000USD | 160,400,000USD | 80,000,000USD | 0USD | 0USD | 0USD |
| Net Interest Income | -151,800,000USD | -131,100,000USD | -151,200,000USD | -158,500,000USD | -79,100,000USD | — | — | — |
| Income Before Tax | 983,900,000USD | 897,800,000USD | 729,800,000USD | 655,000,000USD | 180,800,000USD | 246,900,000USD | 252,300,000USD | 255,900,000USD |
| Income Tax Expense | 145,200,000USD | 92,500,000USD | 150,900,000USD | 111,500,000USD | 264,100,000USD | 31,300,000USD | 78,900,000USD | 82,800,000USD |
| Tax Provision | 145,200,000USD | 91,600,000USD | 150,900,000USD | 111,500,000USD | 264,100,000USD | — | — | — |
| Net Income | 736,500,000USD | 739,600,000USD | 552,400,000USD | 477,400,000USD | 535,800,000USD | 215,600,000USD | 173,400,000USD | 173,100,000USD |
| Net Income From Continuing Ops | 838,700,000USD | 802,200,000USD | 578,900,000USD | 543,500,000USD | -83,300,000USD | — | — | — |
| Ebit | 1,131,700,000USD | 1,024,700,000USD | 878,400,000USD | 814,700,000USD | 260,800,000USD | 214,100,000USD | 314,700,000USD | 324,700,000USD |
| Ebitda | 1,298,100,000USD | 1,185,300,000USD | 1,036,700,000USD | 1,055,700,000USD | 370,500,000USD | 463,000,000USD | 543,700,000USD | 549,600,000USD |
| Depreciation And Amortization | 166,400,000USD | 160,600,000USD | 158,300,000USD | 241,000,000USD | 109,700,000USD | 248,900,000USD | 229,000,000USD | 224,900,000USD |
| Reconciled Depreciation | 169,400,000USD | 170,900,000USD | 162,700,000USD | 150,100,000USD | 113,000,000USD | — | — | — |
| Total Other Income Expense Net | -307,000,000USD | -268,700,000USD | -390,600,000USD | -321,500,000USD | -323,800,000USD | -116,300,000USD | -62,400,000USD | -68,800,000USD |
| Minority Interest | -5,000,000USD | 2,500,000USD | -900,000USD | -2,800,000USD | 2,600,000USD | — | — | — |
| Discontinued Operations | -97,200,000USD | -68,200,000USD | -28,300,000USD | -63,300,000USD | 621,700,000USD | — | — | — |
| Net Income Applicable To Common Shares | 736,500,000USD | 736,500,000USD | 551,500,000USD | 477,400,000USD | 535,800,000USD | — | — | — |
| Unclassified Operating Expenses | — | — | -93,800,000USD | -75,900,000USD | -138,400,000USD | 248,900,000USD | 229,000,000USD | 855,900,000USD |
| Non Operating Income Net Other | — | — | 100,000USD | 1,900,000USD | 1,000,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,144,800,000USD | 9,419,500,000USD | 9,687,200,000USD | 12,078,800,000USD | 12,297,100,000USD | 11,800,900,000USD | 11,653,300,000USD | 12,218,700,000USD |
| Cash And Equivalents | 476,600,000USD | — | 584,500,000USD | 497,700,000USD | 438,200,000USD | 315,300,000USD | 357,300,000USD | 416,700,000USD |
| Total Current Assets | 4,728,700,000USD | 4,904,900,000USD | 4,959,000,000USD | 5,567,300,000USD | 5,467,300,000USD | 5,077,600,000USD | 4,958,300,000USD | 5,315,500,000USD |
| Other Current Assets | 570,700,000USD | 1,026,600,000USD | 1,092,900,000USD | 1,363,600,000USD | 557,100,000USD | 487,800,000USD | 233,900,000USD | 616,200,000USD |
| Other Non Current Assets | 398,300,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 7,483,700,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,379,400,000USD | 3,813,300,000USD | 3,755,300,000USD | 3,990,600,000USD | 3,573,100,000USD | 3,305,300,000USD | 3,019,200,000USD | 3,588,400,000USD |
| Other Current Liabilities | 606,800,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 520,100,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,636,800,000USD | 1,822,100,000USD | 2,071,500,000USD | 3,773,800,000USD | 4,397,000,000USD | 4,382,000,000USD | 4,487,500,000USD | 4,607,800,000USD |
| Total Equity Including Noncontrolling Interest | 1,661,100,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 3,954,300,000USD | 2,770,600,000USD | 2,769,800,000USD | 3,270,500,000USD | 3,270,000,000USD | 3,027,700,000USD | 3,027,900,000USD | 3,026,800,000USD |
| Deferred Revenue | 35,500,000USD | — | — | — | — | — | — | — |
| Inventory | 1,209,300,000USD | 1,242,600,000USD | 1,219,600,000USD | 1,375,900,000USD | 1,395,700,000USD | 1,374,400,000USD | 1,201,600,000USD | 1,392,100,000USD |
| Property Plant Equipment Net | 554,700,000USD | 627,500,000USD | 707,400,000USD | 855,400,000USD | 890,700,000USD | 858,700,000USD | 960,100,000USD | 869,400,000USD |
| Intangible Assets | 2,307,900,000USD | 2,333,500,000USD | 2,361,800,000USD | 2,379,800,000USD | 2,401,400,000USD | 2,366,600,000USD | 2,472,800,000USD | 2,421,700,000USD |
| Accounts Payable | 657,800,000USD | 634,100,000USD | 771,000,000USD | 733,600,000USD | 906,000,000USD | 801,800,000USD | 768,500,000USD | 802,900,000USD |
| Short Term Debt | 326,300,000USD | 1,789,600,000USD | 1,331,400,000USD | 1,271,700,000USD | 893,300,000USD | 975,800,000USD | 361,900,000USD | 1,043,200,000USD |
| Common Stock | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD |
| Retained Earnings | 3,682,000,000USD | 3,878,800,000USD | 4,170,100,000USD | 5,900,900,000USD | 6,543,100,000USD | 6,549,200,000USD | 6,637,500,000USD | 6,726,400,000USD |
| Accumulated Other Comprehensive Income | -324,700,000USD | -329,200,000USD | -368,700,000USD | -391,300,000USD | -403,700,000USD | -415,100,000USD | -410,600,000USD | -373,400,000USD |
| Total Liab | — | 7,569,600,000USD | 7,588,300,000USD | 8,278,000,000USD | 7,869,000,000USD | 7,389,300,000USD | 7,144,500,000USD | 7,588,600,000USD |
| Other Current Liab | — | 1,166,700,000USD | 1,175,800,000USD | 1,907,400,000USD | 1,696,300,000USD | 1,423,100,000USD | 1,312,500,000USD | 1,658,700,000USD |
| Capital Stock | — | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD |
| Cash | — | 390,900,000USD | 584,500,000USD | 497,700,000USD | 438,200,000USD | 315,300,000USD | 357,300,000USD | 416,700,000USD |
| Cash And Short Term Investments | — | 390,900,000USD | 584,500,000USD | 497,700,000USD | 438,200,000USD | 315,300,000USD | 357,300,000USD | 416,700,000USD |
| Current Deferred Revenue | — | 196,300,000USD | 453,100,000USD | — | — | 1,800,000USD | 453,800,000USD | 400,000USD |
| Net Debt | — | 4,265,700,000USD | 3,614,300,000USD | 4,044,500,000USD | 3,725,100,000USD | 3,688,200,000USD | 3,138,600,000USD | 3,653,300,000USD |
| Short Long Term Debt | — | 1,763,000,000USD | 1,305,100,000USD | 1,271,700,000USD | 893,300,000USD | 975,800,000USD | 337,400,000USD | 1,043,200,000USD |
| Short Long Term Debt Total | — | 4,656,600,000USD | 4,198,800,000USD | 4,542,200,000USD | 4,163,300,000USD | 4,003,500,000USD | 3,495,900,000USD | 4,070,000,000USD |
| Long Term Investments | — | 20,600,000USD | 20,400,000USD | 22,700,000USD | 27,700,000USD | 26,100,000USD | 25,600,000USD | 25,300,000USD |
| Net Receivables | — | 2,244,800,000USD | 2,062,000,000USD | 2,330,100,000USD | 3,076,300,000USD | 2,900,100,000USD | 3,165,500,000USD | 2,890,500,000USD |
| Property Plant Equipment Gross | — | 1,603,400,000USD | 1,707,500,000USD | 1,695,700,000USD | 1,682,900,000USD | 1,620,900,000USD | 1,708,300,000USD | 1,616,300,000USD |
| Common Stock Shares Outstanding | — | 125,300,000shares | 125,200,000shares | 125,100,000shares | 125,500,000shares | 125,081,000shares | 125,500,000shares | 125,500,000shares |
| Non Current Assets Total | — | 4,514,600,000USD | 4,728,200,000USD | 6,511,500,000USD | 6,829,800,000USD | 6,723,300,000USD | 6,695,000,000USD | 6,903,200,000USD |
| Non Current Liabilities Total | — | 3,756,300,000USD | 3,833,000,000USD | 4,287,400,000USD | 4,295,900,000USD | 4,084,000,000USD | 4,125,300,000USD | 4,000,200,000USD |
| Non Current Liabilities Other | — | 339,900,000USD | 86,300,000USD | 388,400,000USD | 386,700,000USD | 429,900,000USD | 82,800,000USD | 386,400,000USD |
| Non Currrent Assets Other | — | 206,900,000USD | 343,100,000USD | 437,600,000USD | 433,500,000USD | 429,600,000USD | 205,700,000USD | 447,900,000USD |
| Net Working Capital | — | 1,091,600,000USD | 1,203,700,000USD | 1,576,700,000USD | 1,894,200,000USD | 1,772,300,000USD | 1,939,100,000USD | 1,727,100,000USD |
| Unclassified Non Current Assets | — | 1,326,100,000USD | -163,100,000USD | -262,400,000USD | -270,800,000USD | -314,700,000USD | -278,100,000USD | -330,600,000USD |
| Unclassified Current Liabilities | — | -1,736,400,000USD | -1,281,100,000USD | -1,193,800,000USD | -815,800,000USD | -873,000,000USD | -214,900,000USD | -960,000,000USD |
| Unclassified Non Current Liabilities | — | 645,800,000USD | 976,900,000USD | 628,500,000USD | 639,200,000USD | 626,400,000USD | 1,014,600,000USD | 587,000,000USD |
| Unclassified Equity | — | -1,764,700,000USD | -1,767,100,000USD | -1,773,000,000USD | -1,779,600,000USD | -1,789,300,000USD | -1,776,600,000USD | -1,782,400,000USD |
| Good Will | — | — | 0USD | 1,359,300,000USD | 1,527,000,000USD | 1,515,100,000USD | 1,507,000,000USD | 1,517,800,000USD |
| Other Assets | — | — | 1,458,600,000USD | 1,719,100,000USD | 1,820,300,000USD | 1,841,900,000USD | 1,801,900,000USD | 1,951,700,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,687,200,000USD | 11,653,300,000USD | 11,926,200,000USD | 11,171,300,000USD | 10,673,100,000USD | 10,186,400,000USD | 9,872,700,000USD | 9,974,300,000USD |
| Intangible Assets | 2,361,800,000USD | 2,360,700,000USD | 2,588,400,000USD | 2,641,100,000USD | 2,665,700,000USD | 2,783,200,000USD | 2,746,000,000USD | 2,767,500,000USD |
| Other Current Assets | 1,092,900,000USD | 233,900,000USD | 157,000,000USD | 171,200,000USD | 205,200,000USD | 183,100,000USD | 258,299,999USD | 511,300,000USD |
| Total Liab | 7,588,300,000USD | 7,144,500,000USD | 7,492,800,000USD | 7,770,400,000USD | 7,529,400,000USD | 7,202,200,000USD | 7,311,300,000USD | 6,763,900,000USD |
| Total Stockholder Equity | 2,071,500,000USD | 4,487,500,000USD | 4,410,900,000USD | 3,377,900,000USD | 3,124,300,000USD | 2,961,800,000USD | 2,532,300,000USD | 3,121,100,000USD |
| Other Current Liab | 1,175,800,000USD | 1,312,500,000USD | 1,217,300,000USD | 1,189,400,000USD | 1,142,900,000USD | 1,089,100,000USD | 1,009,700,000USD | 1,105,000,000USD |
| Common Stock | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD |
| Capital Stock | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD | 18,600,000USD |
| Retained Earnings | 4,170,100,000USD | 6,637,500,000USD | 6,587,100,000USD | 5,555,900,000USD | 5,092,900,000USD | 4,506,400,000USD | 4,188,800,000USD | 4,334,300,000USD |
| Good Will | 0USD | 1,507,000,000USD | 1,593,600,000USD | 1,589,300,000USD | 1,463,300,000USD | 1,468,900,000USD | 1,467,500,000USD | 1,468,100,000USD |
| Other Assets | 1,363,800,000USD | 1,689,800,000USD | 1,561,500,000USD | 453,600,000USD | 841,500,000USD | 947,000,000USD | 661,000,000USD | 953,200,000USD |
| Cash | 584,500,000USD | 357,300,000USD | 302,400,000USD | 572,000,000USD | 516,800,000USD | 568,900,000USD | 339,100,000USD | 161,700,000USD |
| Cash And Equivalents | 584,500,000USD | 357,300,000USD | 302,400,000USD | 572,000,000USD | 516,800,000USD | 568,900,000USD | 339,100,000USD | 134,400,000USD |
| Cash And Short Term Investments | 584,500,000USD | 357,300,000USD | 302,400,000USD | 572,000,000USD | 516,800,000USD | 568,900,000USD | 339,100,000USD | 190,800,000USD |
| Total Current Assets | 4,959,000,000USD | 4,958,300,000USD | 5,129,100,000USD | 5,438,600,000USD | 5,053,800,000USD | 4,375,600,000USD | 4,074,800,000USD | 4,030,200,000USD |
| Total Current Liabilities | 3,755,300,000USD | 3,019,200,000USD | 3,384,600,000USD | 3,799,600,000USD | 3,520,300,000USD | 2,829,000,000USD | 2,723,900,000USD | 2,993,400,000USD |
| Current Deferred Revenue | 453,100,000USD | 453,800,000USD | 482,100,000USD | 680,500,000USD | 712,700,000USD | 347,100,000USD | 492,700,000USD | 561,500,000USD |
| Net Debt | 3,614,300,000USD | 3,138,600,000USD | 3,802,800,000USD | 2,852,600,000USD | 2,819,200,000USD | 2,875,600,000USD | 3,114,400,000USD | 2,582,300,000USD |
| Short Term Debt | 1,331,400,000USD | 361,900,000USD | 958,400,000USD | 562,800,000USD | 464,300,000USD | 363,900,000USD | 259,200,000USD | 547,700,000USD |
| Short Long Term Debt | 1,305,100,000USD | 337,400,000USD | 934,000,000USD | 540,800,000USD | 440,800,000USD | 338,300,000USD | 227,700,000USD | 547,700,000USD |
| Short Long Term Debt Total | 4,198,800,000USD | 3,495,900,000USD | 4,105,200,000USD | 3,424,600,000USD | 3,336,000,000USD | 3,444,500,000USD | 3,453,500,000USD | 2,744,000,000USD |
| Long Term Debt | 2,769,800,000USD | 3,027,900,000USD | 3,023,600,000USD | 2,733,200,000USD | 2,731,700,000USD | 2,929,500,000USD | 3,031,100,000USD | 2,179,000,000USD |
| Long Term Investments | 20,400,000USD | 25,600,000USD | 19,800,000USD | 14,500,000USD | 9,200,000USD | 3,100,000USD | 700,000USD | 700,000USD |
| Net Receivables | 2,062,000,000USD | 3,165,500,000USD | 2,945,100,000USD | 3,043,800,000USD | 2,809,900,000USD | 2,528,000,000USD | 2,460,400,000USD | 2,359,000,000USD |
| Inventory | 1,219,600,000USD | 1,201,600,000USD | 1,724,600,000USD | 1,651,600,000USD | 1,521,900,000USD | 1,095,600,000USD | 1,017,000,000USD | 1,097,300,000USD |
| Accounts Payable | 771,000,000USD | 768,500,000USD | 602,400,000USD | 1,252,200,000USD | 1,135,000,000USD | 946,700,000USD | 900,100,000USD | 795,500,000USD |
| Property Plant Equipment Net | 707,400,000USD | 849,700,000USD | 1,014,300,000USD | 973,400,000USD | 952,200,000USD | 919,000,000USD | 922,700,000USD | 1,032,600,000USD |
| Property Plant Equipment Gross | 1,707,500,000USD | 1,708,300,000USD | 1,681,600,000USD | 849,600,000USD | 817,000,000USD | 919,000,000USD | 922,700,000USD | 1,032,600,000USD |
| Accumulated Other Comprehensive Income | -368,700,000USD | -410,600,000USD | -406,500,000USD | -459,600,000USD | -325,500,000USD | -282,200,000USD | -412,000,000USD | -308,900,000USD |
| Common Stock Shares Outstanding | 125,200,000shares | 125,200,000shares | 125,533,000shares | 126,707,000shares | 129,145,999shares | 130,584,000shares | 132,002,000shares | 135,900,000shares |
| Non Current Assets Total | 4,728,200,000USD | 6,695,000,000USD | 6,797,100,000USD | 5,732,700,000USD | 5,619,300,000USD | 5,810,799,999USD | 5,797,900,000USD | 5,944,100,000USD |
| Non Current Liabilities Total | 3,833,000,000USD | 4,125,300,000USD | 4,108,200,000USD | 3,970,800,000USD | 4,009,100,000USD | 4,373,200,000USD | 4,587,400,000USD | 3,770,500,000USD |
| Non Current Liabilities Other | 86,300,000USD | 82,800,000USD | 88,600,000USD | 1,237,600,000USD | 1,277,400,000USD | 1,093,700,000USD | 1,223,100,000USD | 1,260,700,000USD |
| Non Currrent Assets Other | 343,100,000USD | 428,200,000USD | 244,400,000USD | 303,700,000USD | 334,800,000USD | 275,799,999USD | 265,500,000USD | 356,800,000USD |
| Net Working Capital | 1,203,700,000USD | 1,939,100,000USD | 1,744,500,000USD | 1,639,000,000USD | 1,417,300,000USD | 1,546,600,000USD | 1,350,900,000USD | 1,036,800,000USD |
| Unclassified Non Current Assets | -68,300,000USD | -166,000,000USD | -224,900,000USD | -242,900,000USD | -647,400,000USD | -586,200,000USD | -265,500,000USD | -634,800,000USD |
| Unclassified Current Liabilities | -1,281,100,000USD | -214,900,000USD | -809,600,000USD | -426,100,000USD | -375,400,000USD | -256,100,000USD | -165,500,000USD | -564,000,000USD |
| Unclassified Non Current Liabilities | 976,900,000USD | 1,014,600,000USD | 996,000,000USD | -1,430,500,000USD | -1,619,800,000USD | -1,443,700,000USD | -1,393,100,000USD | -1,608,200,000USD |
| Unclassified Equity | -1,767,100,000USD | -1,776,600,000USD | -1,806,900,000USD | 890,600,000USD | 861,800,000USD | 841,600,000USD | 811,100,000USD | 757,600,000USD |
| Deferred Long Term Liab | — | — | — | 321,500,000USD | 342,400,000USD | 350,000,000USD | 333,200,000USD | 330,800,000USD |
| Other Liab | — | — | — | 1,109,000,000USD | 1,277,400,000USD | 1,443,700,000USD | 1,393,100,000USD | 1,608,200,000USD |
| Short Term Investments | — | — | — | 12,400,000USD | 3,700,000USD | 100,000USD | — | 29,100,000USD |
| Treasury Stock | — | — | — | -2,646,200,000USD | -2,542,100,000USD | -2,141,200,000USD | -2,092,800,000USD | -1,699,100,000USD |
| Net Tangible Assets | — | — | — | 869,800,000USD | -933,300,000USD | 336,600,000USD | -1,564,200,000USD | -1,051,300,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -128,200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -261,300,000USD | -1,692,400,000USD | -548,200,000USD | 44,400,000USD | -8,600,000USD | 28,800,000USD | 65,700,000USD | 298,000,000USD |
| Depreciation | 42,000,000USD | 126,700,000USD | 43,400,000USD | 43,400,000USD | 43,700,000USD | 43,100,000USD | 48,000,000USD | 44,300,000USD |
| Stock Based Compensation | 3,000,000USD | 6,100,000USD | 6,800,000USD | 6,900,000USD | 4,200,000USD | 5,700,000USD | 18,100,000USD | 4,900,000USD |
| Other Non Cash Items | 19,500,000USD | 1,558,700,000USD | 539,700,000USD | -2,400,000USD | -56,600,000USD | -4,800,000USD | -51,300,000USD | 67,400,000USD |
| Change To Account Receivables | -79,700,000USD | 540,000,000USD | -165,300,000USD | -165,800,000USD | 19,500,000USD | -78,900,000USD | -175,100,000USD | 48,800,000USD |
| Change To Inventory | -82,500,000USD | -9,700,000USD | 18,900,000USD | -600,000USD | -164,900,000USD | 174,500,000USD | 57,200,000USD | 116,800,000USD |
| Change In Working Capital | -549,900,000USD | 445,100,000USD | -333,600,000USD | -46,800,000USD | -559,400,000USD | 290,600,000USD | 15,500,000USD | 245,100,000USD |
| Total Cash From Operating Activities | -616,600,000USD | 636,800,000USD | -208,200,000USD | 49,500,000USD | -558,300,000USD | 399,500,000USD | 141,200,000USD | 294,800,000USD |
| Capital Expenditures | -16,600,000USD | 70,300,000USD | -23,700,000USD | -15,000,000USD | -31,600,000USD | -21,600,000USD | -15,700,000USD | -9,900,000USD |
| Free Cash Flow | -633,200,000USD | 707,099,999USD | -231,900,000USD | 34,500,000USD | -589,900,000USD | 377,900,000USD | 125,500,000USD | 284,900,000USD |
| Total Cashflows From Investing Activities | -16,200,000USD | -15,300,000USD | -33,000,000USD | -13,400,000USD | -38,000,000USD | 319,500,000USD | -16,300,000USD | -15,900,000USD |
| Net Borrowings | 453,200,000USD | -471,300,000USD | 381,600,000USD | 163,700,000USD | 634,900,000USD | -695,800,000USD | -112,400,000USD | — |
| Total Cash From Financing Activities | 442,300,000USD | -546,100,000USD | 303,400,000USD | 76,600,000USD | 552,100,000USD | -768,600,000USD | -186,200,000USD | -221,000,000USD |
| Dividends Paid | -10,000,000USD | -72,900,000USD | -72,900,000USD | -72,800,000USD | -72,700,000USD | -72,700,000USD | -72,700,000USD | -72,700,000USD |
| Sale Purchase Of Stock | -900,000USD | -100,000USD | -300,000USD | -1,200,000USD | -1,400,000USD | -100,000USD | -400,000USD | -100,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 0USD | 0USD | 200,000USD | 0USD | 0USD | 200,000USD |
| Change In Cash | -193,600,000USD | 86,800,000USD | 59,500,000USD | 122,900,000USD | -42,000,000USD | -59,400,000USD | -54,800,000USD | 53,700,000USD |
| Begin Period Cash Flow | 584,500,000USD | 497,700,000USD | 438,200,000USD | 315,300,000USD | 357,300,000USD | 416,700,000USD | 471,500,000USD | 417,800,000USD |
| End Period Cash Flow | 390,900,000USD | 584,500,000USD | 497,700,000USD | 438,200,000USD | 315,300,000USD | 357,300,000USD | 416,700,000USD | 471,500,000USD |
| Other Cashflows From Investing Activities | 800,000USD | 12,400,000USD | -600,000USD | 5,200,000USD | -5,800,000USD | 1,500,000USD | 2,000,000USD | -4,500,000USD |
| Unclassified Operating Cash Flow | 130,100,000USD | 192,600,000USD | 83,700,000USD | 4,000,000USD | 18,400,000USD | 36,100,000USD | 45,200,000USD | -364,900,000USD |
| Other Cashflows From Financing Activities | — | -545,900,000USD | 9,600,000USD | -14,300,000USD | -8,900,000USD | -700,000USD | -700,000USD | -15,900,000USD |
| Unclassified Investing Cash Flow | — | -98,000,000USD | 24,300,000USD | 9,800,000USD | 37,400,000USD | 20,100,000USD | 13,700,000USD | 14,400,000USD |
| Unclassified Financing Cash Flow | — | 544,100,000USD | -14,600,000USD | 1,200,000USD | — | — | — | -132,300,000USD |
| Investments | — | — | -33,000,000USD | -13,400,000USD | -38,000,000USD | 319,500,000USD | -16,300,000USD | -15,900,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20182018-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,203,400,000USD | 401,700,000USD | 1,417,300,000USD | 654,900,000USD | 245,400,000USD | -177,900,000USD | 411,500,000USD | 467,300,000USD |
| Depreciation | 273,000,000USD | 169,400,000USD | 251,200,000USD | 168,200,000USD | 137,100,000USD | 115,700,000USD | 131,200,000USD | 127,200,000USD |
| Stock Based Compensation | 24,000,000USD | 23,800,000USD | 25,900,000USD | 23,000,000USD | 20,200,000USD | 15,400,000USD | 14,800,000USD | 14,200,000USD |
| Other Non Cash Items | 2,147,600,000USD | 182,800,000USD | 15,200,000USD | -218,100,000USD | -21,300,000USD | 65,600,000USD | -58,200,000USD | -29,200,000USD |
| Change To Account Receivables | 228,400,000USD | -348,800,000USD | 192,400,000USD | -302,200,000USD | -6,100,000USD | 140,900,000USD | -276,900,000USD | -394,500,000USD |
| Change To Inventory | -156,300,000USD | 475,800,000USD | -72,800,000USD | -224,200,000USD | 72,500,000USD | 78,300,000USD | 33,100,000USD | 5,100,000USD |
| Change In Working Capital | -602,200,000USD | 233,700,000USD | -803,200,000USD | -212,200,000USD | 58,300,000USD | -396,400,000USD | -64,600,000USD | -270,400,000USD |
| Total Cash From Operating Activities | -80,200,000USD | 671,100,000USD | -386,400,000USD | 368,400,000USD | 497,800,000USD | -357,700,000USD | 373,700,000USD | 328,700,000USD |
| Capital Expenditures | -96,300,000USD | -67,900,000USD | -133,900,000USD | -156,600,000USD | -130,800,000USD | -108,500,000USD | -224,700,000USD | -221,900,000USD |
| Free Cash Flow | -176,500,000USD | 603,200,000USD | -520,300,000USD | 211,800,000USD | 367,000,000USD | -466,200,000USD | 149,000,000USD | 106,800,000USD |
| Investments | -12,100,000USD | 263,600,000USD | -99,000,000USD | 88,000,000USD | -135,200,000USD | 66,400,000USD | 26,400,000USD | -6,400,000USD |
| Total Cashflows From Investing Activities | -108,300,000USD | 263,600,000USD | -154,400,000USD | -130,900,000USD | -155,200,000USD | 348,800,000USD | -35,200,000USD | -653,200,000USD |
| Net Borrowings | 708,900,000USD | -576,700,000USD | 699,300,000USD | -441,600,000USD | -259,900,000USD | 66,100,000USD | -181,800,000USD | 884,900,000USD |
| Total Cash From Financing Activities | 394,600,000USD | -870,100,000USD | 331,500,000USD | -363,300,000USD | -377,000,000USD | -16,700,000USD | -350,000,000USD | 371,200,000USD |
| Dividends Paid | -291,300,000USD | -290,600,000USD | -290,500,000USD | -89,200,000USD | -88,600,000USD | -86,400,000USD | -78,100,000USD | -73,600,000USD |
| Sale Purchase Of Stock | -1,800,000USD | -2,300,000USD | -81,200,000USD | -206,800,000USD | -13,000,000USD | -3,700,000USD | -4,700,000USD | -367,000,000USD |
| Issuance Of Capital Stock | 200,000USD | 200,000USD | 6,200,000USD | 374,300,000USD | — | — | — | — |
| Change In Cash | 227,200,000USD | 54,900,000USD | -269,600,000USD | -121,300,000USD | -14,400,000USD | -30,900,000USD | -13,700,000USD | 46,100,000USD |
| Begin Period Cash Flow | 357,300,000USD | 302,400,000USD | 572,000,000USD | 283,000,000USD | 78,600,000USD | 109,500,000USD | 123,200,000USD | 77,100,000USD |
| End Period Cash Flow | 584,500,000USD | 357,300,000USD | 302,400,000USD | 161,700,000USD | 64,200,000USD | 78,600,000USD | 109,500,000USD | 123,200,000USD |
| Other Cashflows From Investing Activities | 11,200,000USD | -3,700,000USD | -4,000,000USD | -21,400,000USD | -45,900,000USD | -1,285,500,000USD | -35,700,000USD | -85,300,000USD |
| Other Cashflows From Financing Activities | -5,000,000USD | -700,000USD | -1,400,000USD | 30,900,000USD | -20,300,000USD | 1,400,000USD | -104,500,000USD | -87,800,000USD |
| Unclassified Operating Cash Flow | 280,800,000USD | -340,300,000USD | -1,292,800,000USD | -47,400,000USD | 58,100,000USD | 19,900,000USD | -61,000,000USD | 19,600,000USD |
| Unclassified Investing Cash Flow | -11,100,000USD | 71,600,000USD | 82,500,000USD | -40,900,000USD | 156,700,000USD | 1,676,400,000USD | 198,800,000USD | -339,600,000USD |
| Unclassified Financing Cash Flow | -16,200,000USD | — | 5,300,000USD | 343,400,000USD | 4,800,000USD | 5,900,000USD | 19,100,000USD | 14,700,000USD |
| Change To Liabilities | — | — | — | 87,400,000USD | -73,900,000USD | -517,800,000USD | 9,400,000USD | 91,100,000USD |
| Exchange Rate Changes | — | — | — | 4,500,000USD | — | -5,300,000USD | -2,200,000USD | -600,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -121,300,000USD | -14,400,000USD | -30,900,000USD | -13,700,000USD | 46,100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Asia | 126,300,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | EMEA | 214,100,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Latin America | 277,900,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | North America | 248,800,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Fungicides | 88,400,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Herbicides | 318,200,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Insecticides | 423,500,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Plant Health | 36,300,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product And Service Other | 700,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia | 77,100,000 | USD | 0000037785-26-000096 |
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 306,900,000 | USD | 0000037785-26-000096 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Latin America | 177,000,000 | USD | 0000037785-26-000096 |
| Q1 2026Quarterly · 2026-03-31 | Geography | North America | 197,600,000 | USD | 0000037785-26-000096 |
| Q1 2026Quarterly · 2026-03-31 | Product | Fungicides | 55,800,000 | USD | 0000037785-26-000096 |
| Q1 2026Quarterly · 2026-03-31 | Product | Herbicides | 313,700,000 | USD | 0000037785-26-000096 |
| Q1 2026Quarterly · 2026-03-31 | Product | Insecticides | 340,600,000 | USD | 0000037785-26-000096 |
| Q1 2026Quarterly · 2026-03-31 | Product | Plant Health | 47,800,000 | USD | 0000037785-26-000096 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Other | 700,000 | USD | 0000037785-26-000096 |
| Q4 2025Quarterly · 2025-12-31 | Product | Fungicides | 140,400,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Herbicides | 378,800,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Insecticides | 440,300,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Plant Health | 65,600,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product And Service Other | 58,200,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Fungicides | 362,800,000 | USD | 0000037785-26-000041 |
| FY 2025Yearly · 2025-12-31 | Product | Herbicides | 1,246,900,000 | USD | 0000037785-26-000041 |
| FY 2025Yearly · 2025-12-31 | Product | Insecticides | 1,572,700,000 | USD | 0000037785-26-000041 |
| FY 2025Yearly · 2025-12-31 | Product | Plant Health | 190,900,000 | USD | 0000037785-26-000041 |
| FY 2025Yearly · 2025-12-31 | Product | Product And Service Other | 94,100,000 | USD | 0000037785-26-000041 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Asia | -319,800,000 | USD | 0000037785-25-000127 |
| Q3 2025Quarterly · 2025-09-30 | Geography | EMEA | 154,500,000 | USD | 0000037785-25-000127 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Latin America | 463,100,000 | USD | 0000037785-25-000127 |
| Q3 2025Quarterly · 2025-09-30 | Geography | North America | 244,400,000 | USD | 0000037785-25-000127 |
| Q3 2025Quarterly · 2025-09-30 | Product | Fungicides | 89,300,000 | USD | 0000037785-25-000127 |
| Q3 2025Quarterly · 2025-09-30 | Product | Herbicides | 219,900,000 | USD | 0000037785-25-000127 |
| Q3 2025Quarterly · 2025-09-30 | Product | Insecticides | 204,400,000 | USD | 0000037785-25-000127 |
| Q3 2025Quarterly · 2025-09-30 | Product | Plant Health | 35,200,000 | USD | 0000037785-25-000127 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Other | -6,600,000 | USD | 0000037785-25-000127 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Asia | 158,800,000 | USD | 0000037785-25-000083 |
| Q2 2025Quarterly · 2025-06-30 | Geography | EMEA | 260,400,000 | USD | 0000037785-25-000083 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Latin America | 310,400,000 | USD | 0000037785-25-000083 |
| Q2 2025Quarterly · 2025-06-30 | Geography | North America | 320,900,000 | USD | 0000037785-25-000083 |
| Q2 2025Quarterly · 2025-06-30 | Product | Fungicides | 80,400,000 | USD | 0000037785-25-000083 |
| Q2 2025Quarterly · 2025-06-30 | Product | Herbicides | 376,000,000 | USD | 0000037785-25-000083 |
| Q2 2025Quarterly · 2025-06-30 | Product | Insecticides | 525,300,000 | USD | 0000037785-25-000083 |
| Q2 2025Quarterly · 2025-06-30 | Product | Plant Health | 44,900,000 | USD | 0000037785-25-000083 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Other | 23,900,000 | USD | 0000037785-25-000083 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia | 125,400,000 | USD | 0000037785-26-000096 |
| Q1 2025Quarterly · 2025-03-31 | Geography | EMEA | 272,800,000 | USD | 0000037785-26-000096 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Latin America | 206,800,000 | USD | 0000037785-26-000096 |
| Q1 2025Quarterly · 2025-03-31 | Geography | North America | 186,400,000 | USD | 0000037785-26-000096 |
| Q1 2025Quarterly · 2025-03-31 | Product | Fungicides | 52,700,000 | USD | 0000037785-26-000096 |
| Q1 2025Quarterly · 2025-03-31 | Product | Herbicides | 272,200,000 | USD | 0000037785-26-000096 |
| Q1 2025Quarterly · 2025-03-31 | Product | Insecticides | 402,700,000 | USD | 0000037785-26-000096 |
| Q1 2025Quarterly · 2025-03-31 | Product | Plant Health | 45,200,000 | USD | 0000037785-26-000096 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Other | 18,600,000 | USD | 0000037785-26-000096 |
| Q4 2024Quarterly · 2024-12-31 | Product | Fungicides | 122,800,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Herbicides | 373,400,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Insecticides | 659,600,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Plant Health | 64,900,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product And Service Other | 3,600,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Fungicides | 352,500,000 | USD | 0000037785-26-000041 |
| FY 2024Yearly · 2024-12-31 | Product | Herbicides | 1,280,500,000 | USD | 0000037785-26-000041 |
| FY 2024Yearly · 2024-12-31 | Product | Insecticides | 2,377,900,000 | USD | 0000037785-26-000041 |
| FY 2024Yearly · 2024-12-31 | Product | Plant Health | 200,500,000 | USD | 0000037785-26-000041 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Other | 34,700,000 | USD | 0000037785-26-000041 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Asia | 186,500,000 | USD | 0000037785-25-000127 |
| Q3 2024Quarterly · 2024-09-30 | Geography | EMEA | 139,300,000 | USD | 0000037785-25-000127 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Latin America | 504,100,000 | USD | 0000037785-25-000127 |
| Q3 2024Quarterly · 2024-09-30 | Geography | North America | 235,500,000 | USD | 0000037785-25-000127 |
| Q3 2024Quarterly · 2024-09-30 | Product | Fungicides | 84,800,000 | USD | 0000037785-25-000127 |
| Q3 2024Quarterly · 2024-09-30 | Product | Herbicides | 275,600,000 | USD | 0000037785-25-000127 |
| Q3 2024Quarterly · 2024-09-30 | Product | Insecticides | 647,900,000 | USD | 0000037785-25-000127 |
| Q3 2024Quarterly · 2024-09-30 | Product | Plant Health | 47,300,000 | USD | 0000037785-25-000127 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product And Service Other | 9,800,000 | USD | 0000037785-25-000127 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Asia | 191,200,000 | USD | 0000037785-25-000083 |
| Q2 2024Quarterly · 2024-06-30 | Geography | EMEA | 201,200,000 | USD | 0000037785-25-000083 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Latin America | 307,200,000 | USD | 0000037785-25-000083 |
| Q2 2024Quarterly · 2024-06-30 | Geography | North America | 338,800,000 | USD | 0000037785-25-000083 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Asia | 164,100,000 | USD | 0000037785-25-000065 |
| Q1 2024Quarterly · 2024-03-31 | Geography | EMEA | 306,800,000 | USD | 0000037785-25-000065 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Latin America | 188,000,000 | USD | 0000037785-25-000065 |
| Q1 2024Quarterly · 2024-03-31 | Geography | North America | 259,100,000 | USD | 0000037785-25-000065 |
| FY 2023Yearly · 2023-12-31 | Product | Fungicides | 317,600,000 | USD | 0000037785-26-000041 |
| FY 2023Yearly · 2023-12-31 | Product | Herbicides | 1,278,400,000 | USD | 0000037785-26-000041 |
| FY 2023Yearly · 2023-12-31 | Product | Insecticides | 2,639,400,000 | USD | 0000037785-26-000041 |
| FY 2023Yearly · 2023-12-31 | Product | Plant Health | 186,900,000 | USD | 0000037785-26-000041 |
| FY 2023Yearly · 2023-12-31 | Product | Product And Service Other | 64,500,000 | USD | 0000037785-26-000041 |
| FY 2023Yearly · 2023-12-31 | Geography | Asia Pacific | 981,700,000 | USD | 0000037785-24-000033 |
| FY 2023Yearly · 2023-12-31 | Geography | EMEA | 899,200,000 | USD | 0000037785-24-000033 |
| FY 2023Yearly · 2023-12-31 | Geography | Latin America | 1,401,100,000 | USD | 0000037785-24-000033 |
| FY 2023Yearly · 2023-12-31 | Geography | North America | 1,204,800,000 | USD | 0000037785-24-000033 |
| FY 2022Yearly · 2022-12-31 | Product | Fungicides | 383,900,000 | USD | 0000037785-25-000030 |
| FY 2022Yearly · 2022-12-31 | Product | Herbicides | 1,651,600,000 | USD | 0000037785-25-000030 |
| FY 2022Yearly · 2022-12-31 | Product | Insecticides | 3,346,600,000 | USD | 0000037785-25-000030 |
| FY 2022Yearly · 2022-12-31 | Product | Plant Health | 234,100,000 | USD | 0000037785-25-000030 |
| FY 2022Yearly · 2022-12-31 | Product | Product And Service Other | 186,100,000 | USD | 0000037785-25-000030 |
| FY 2022Yearly · 2022-12-31 | Geography | Asia Pacific | 1,238,600,000 | USD | 0000037785-24-000033 |
| FY 2022Yearly · 2022-12-31 | Geography | EMEA | 1,039,700,000 | USD | 0000037785-24-000033 |
| FY 2022Yearly · 2022-12-31 | Geography | Latin America | 2,088,200,000 | USD | 0000037785-24-000033 |
| FY 2022Yearly · 2022-12-31 | Geography | North America | 1,435,800,000 | USD | 0000037785-24-000033 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.